The DOI matches its Crossref record.
Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
Open accessAbstract
Freshly isolated human neutrophils were investigated for their ability to degrade heparan sulfate proteoglycans in the subendothelial extracellular matrix (ECM) produced by cultured corneal and vascular endothelial cells. The ECM was metabolically labeled with Na2(35S)O4 and labeled degradation products were analyzed by gel filtration over Sepharose 6B. More than 90% of the released radioactivity consisted of heparan sulfate fragments 5-6 times smaller than intact heparan sulfate side chains released from the ECM by either papain or alkaline borohydride. These fragments were sensitive to deamination with nitrous acid and were not produced in the presence of either heparin or serine protease inhibitors. In contrast, degradation of soluble high molecular weight heparan sulfate proteoglycan, which was first released from the ECM, was inhibited by heparin but there was no effect of protease inhibitors. These results indicate that interaction of human neutrophils with the subendothelial ECM is associated with degradation of its heparan sulfate by means of a specific, newly identified, heparanase activity and that this degradation is facilitated to a large extent by serine proteases. The neutrophil heparanase was readily and preferentially released (15-25% of the cellular content in 60 min) by simply incubating the cells at 4 degrees C in the absence of added stimuli. Under these conditions, less than 5% of the cellular content of lactate dehydrogenase, lysozyme, and globin degrading proteases was released. Further purification of the neutrophil heparanase was achieved by its binding to heparin-Sepharose and elution at 1 M NaCl. It is suggested that heparanase activity is involved in the early events of extravasation and diapedesis of neutrophils in response to a threshold signal from an extravascular inflamed organ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pries, A. R., Secomb, T. W., & Gaehtgens, P. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000307 · Cited by 898
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Self-citationTransplantation of discordant xenografts: a review of progress
Platt, J. L., Vercellotti, G. M., Dalmasso, A. P., Matas, A. J., Bolman, R. M., Najarian, J. S., & Bach, F. H. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90174-8 · Cited by 536
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T., Harris, M. J., & Parish, C. R. (1999) · Nature Medicine · doi:10.1038/10525 · Cited by 518
Gospodarowicz, D., Neufeld, G., & Schweigerer, L. (1986) · Cell Differentiation · doi:10.1016/0045-6039(86)90021-7 · Cited by 466
De Larco, J. E., Wuertz, B. R. K., & Furcht, L. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0760 · Cited by 412
Baird, A., & Ling, N. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90292-0 · Cited by 411
Cell biology of arterial proteoglycans.
Wight, T. N. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.1 · Cited by 410
Gospodarowicz, D., Neufeld, G., & Schweigerer, L. (1986) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(86)90001-8 · Cited by 365
De Cicco, P., Ercolano, G., & Ianaro, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01680 · Cited by 332
Platt, J. L., Vercellotti, G. M., Lindman, B. J., Oegema, T. R., Bach, F. H., & Dalmasso, A. P. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.4.1363 · Cited by 273
Recent studies on the structure and pathology of basement membranes
Abrahamson, D. R. (1986) · The Journal of Pathology · doi:10.1002/path.1711490402 · Cited by 254
Calcium-Dependent Heparin-Like Ligands For L-Selectin in Nonlymphoid Endothelial Cells
Norgard-Sumnicht, K. E., Varki, N. M., & Varki, A. (1993) · Science · doi:10.1126/science.7687382 · Cited by 197
Metadata
- Authors
- Matzner, Y., Bar-Ner, M., Yahalom, J., Ishai-Michaeli, R., Fuks, Z., & Vlodavsky, I.
- Venue
- Journal of Clinical Investigation
- Published
- 1985-10-01
- Volume
- 76
- Issue
- 4
- Pages
- 1306-1313
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1993165881
- Cited by
- 212
- References
- 0
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.